Showing results (311-320 of 330) with videos related to

Sort By:
Pageof 33
Annals of the New York Academy of Sciences|November 11, 2008
Short allele of 5-HTTLPR as a risk factor for the development of psychosis in Japanese methamphetamine abusersNorikazu Ezaki, Kazuhiko Nakamura, Yoshimoto Sekine, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 19, 2013
Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophreniaMasashi Ikeda, Yuko Okahisa, Branko Aleksic, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|March 27, 2019
Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trialTeruhiko Higuchi, Masaomi Iyo, Jun Soo Kwon, et al.
Neuroscience Letters|February 22, 2005
A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophreniaYukitaka Morita, Hiroshi Ujike, Yuji Tanaka, et al.
Psychotherapy and Psychosomatics|May 28, 2016
Cognitive Behavioral Therapy for Patients with Social Anxiety Disorder Who Remain Symptomatic following Antidepressant Treatment: A Randomized, Assessor-Blinded, Controlled TrialNaoki Yoshinaga, Satoshi Matsuki, Tomihisa Niitsu, et al.
Archives of General Psychiatry|March 5, 2008
Genome-wide association for methamphetamine dependence: convergent results from 2 samplesGeorge R Uhl, Tomas Drgon, Qing-Rong Liu, et al.
Psychiatric Genetics|July 11, 2006
An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorderAtsuko Suzuki, Kazuhiko Nakamura, Yoshimoto Sekine, et al.
The American Journal of Psychiatry|July 4, 2007
Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosisDaisuke Matsuzawa, Kenji Hashimoto, Ryosuke Miyatake, et al.
Schizophrenia Research|March 27, 2014
A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosisHiroshi Kimura, Nobuhisa Kanahara, Naoya Komatsu, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 26, 2009
Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorderYoshimi Iwayama, Eiji Hattori, Motoko Maekawa, et al.
Pageof 33